I don'now , but I will think pivotal mono should b
Post# of 148271
But FDA will do what they want to do of course ,
I feel that even if it will take all new patients , but efficacy was significantly better with longer overlap of 3 weeks instead 1 week with investigative phase 3, we should do longer overlap.
We should not need more than 150 patients...
This is mine wish list !!!!